CD4 and cancer: Besides, we observed positive correlations between BRIP1 expression and the immune pathways of “activated CD4 T cell,” “memory B cell,” and “type 2 T helper cell,” and immune checkpoints in many cancers, which would help us to further understand the role of BRIP1 in specific tumor’s immune microenvironment.